Action ABB AB-BIOTICS, S.A.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues AB-Biotics, S.A.

Actions

ABB

ES0109659013

Cours en clôture BME
Autres places de cotation
 		Varia. 5j. Varia. 1 janv.
- EUR -.--% Graphique intraday de AB-Biotics, S.A. -.--% -.--%
2022 AB-Biotics, S.A. a acquis Alifarm S.A. pour 3,5 millions d'euros. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
AB-Biotics, S.A. acquired Alifarm S.A. for EUR 3.5 million.
Kaneka Europe Holding Company N.V. completed the acquisition of 18.21% stake in AB-Biotics, S.A.
Kaneka Europe Holding Company N.V. made an offer to acquire remaining 33.67% stake in AB-Biotics, S.A. for €21.2 million.
Kaneka Corporation has completed the voluntary offer to acquire an additional 26.57% stake in AB-Biotics, S.A. for €16.7 million.
Kaneka Corporation made a voluntary public offer to acquire the remaining 60.24% stake in AB-Biotics, S.A. for €37.9 million.
Ab-Biotics Sa Reports Earnings Results for the Full Year Ended December 31, 2018
Kaneka Corporation Concludes License Agreement with AB-Biotics for Production and Sales of its Probiotics Products
Kaneka Corporation completed the acquisition of 26.87% stake in AB-Biotics, S.A. from Corporacion Ivamosa, Gestion Y Administracion Mobiliaria, S.A., Capital MAB, FCR fund of Institut Català de Finances Capital, SGEIC, S.A. and Buanaventura Guamis.
Kaneka Americas Holding Inc. enters into Licensing Agreement with AB-Biotics, S.A
Kaneka Corporation signed an agreement to acquire 26.87% stake in AB-Biotics, S.A. from Corporacion Ivamosa, Gestion Y Administracion Mobiliaria, S.A., Capital MAB, FCR fund of Institut Català de Finances Capital, SGEIC, S.A. and Buanaventura Guamis.
Corporacion Ivamosa and Gestion Y Administracion Mobiliaria, S.A. acquired 10% stake in AB-Biotics, S.A..
Frutarom Industries Ltd. acquired AB-Fortis from AB-Biotics, S.A..
AB-Biotics SA announced a financing transaction
AB-Biotics Agrees Distribution Deal with Abbott for I3.1 Probiotic in Spain
DuPont Nutrition & Health and AB-Biotics Announce Agreement on Probiotic for Cardiovascular Health
AB-Biotics Provides Earnings Guidance for the Full Year of 2013
AB-Biotics SA sold Quantum Experimental S.L.
AB-Biotics and Scienta Farma Sign Distribution Agreement to Market Genetic Test Neurofarmagen in Mexico
AB-Biotics SA announced that it expects to receive €1.08 million in funding.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ABB
  4. Actualités AB-Biotics, S.A.
  5. Autres langues